Search research articles
Contact Us
Filters
Showing results (131-140 of 169) with videos related to
Page
of 17
Sort By:
Clinical & Experimental Metastasis
|
October 17, 2018
Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST)
C Liedtke, Hans-Christian Kolberg, L Kerschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients
V Möbus, G von Minckwitz, C Jackisch, et al.
Oncology (Williston Park, N.Y.)
|
February 3, 2005
Anthracycline and trastuzumab in breast cancer treatment
M Untch, I Himsl, S Kahlert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 12, 2022
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
S Loibl, A Schneeweiss, J Huober, et al.
Clinical Chemistry
|
November 24, 2001
Evaluation of the analytical and clinical performance of the Elecsys CA 15-3 immunoassay
P Stieber, R Molina, D W Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 2007
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
M Kaufmann, G von Minckwitz, H D Bear, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2024
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
L Pusztai, C Denkert, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2013
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
B Gerber, S Loibl, H Eidtmann, et al.
Zentralblatt Fur Gynakologie
|
September 17, 2002
[Evidence-based recommendations on treating locoregional and distant metastases of carcinomas of the breast]
G Von Minckwitz, S D Costa, K Brunnert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2004
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial
M Untch, H Eidtmann, A du Bois, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 169) with videos related to
Sort By:
Page
of 17
Clinical & Experimental Metastasis
|
October 17, 2018
Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST)
C Liedtke, Hans-Christian Kolberg, L Kerschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2017
German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients
V Möbus, G von Minckwitz, C Jackisch, et al.
Oncology (Williston Park, N.Y.)
|
February 3, 2005
Anthracycline and trastuzumab in breast cancer treatment
M Untch, I Himsl, S Kahlert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 12, 2022
Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
S Loibl, A Schneeweiss, J Huober, et al.
Clinical Chemistry
|
November 24, 2001
Evaluation of the analytical and clinical performance of the Elecsys CA 15-3 immunoassay
P Stieber, R Molina, D W Chan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 2007
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
M Kaufmann, G von Minckwitz, H D Bear, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2024
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
L Pusztai, C Denkert, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2013
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
B Gerber, S Loibl, H Eidtmann, et al.
Zentralblatt Fur Gynakologie
|
September 17, 2002
[Evidence-based recommendations on treating locoregional and distant metastases of carcinomas of the breast]
G Von Minckwitz, S D Costa, K Brunnert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2004
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial
M Untch, H Eidtmann, A du Bois, et al.
Page
of 17